Viewing data from:

TRANDOLAPRIL

ANDA

TRANDOLAPRIL | A078438 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.1824

per ea

Lowest NADAC/Unit

$0.1494

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
57237009001TRANDOLAPRIL 2 MG TABLET	$0.1824	EA	Generic	—	2026-08-19
57237009101TRANDOLAPRIL 4 MG TABLET	$0.1530	EA	Generic	—	2026-08-19
57237008901TRANDOLAPRIL 1 MG TABLET	$0.1494	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs7 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

LUPIN LTDTRANDOLAPRIL USP

DMF 176582004

ALIVUS LIFE SCIENCES LTDTRANDOLAPRIL USP

DMF 181652005

APITORIA PHARMA PRIVATE LTDTRANDOLAPRIL USP

DMF 195482006

CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTDInactiveTRANDOLAPRIL USP

DMF 175732004

HETERO DRUGS LTDInactiveTRANDOLAPRIL

DMF 176222004

DR REDDYS LABORATORIES LTDInactiveTRANDOLAPRIL

DMF 184672005

ROLABO OUTSOURCING SLInactiveTRANDOLAPRIL

DMF 189472005

WOCKHARDT LTDInactiveTRANDOLAPRIL

DMF 197202006

VITALIFE LABORATORIES (A DIV ARCH PHARMALABS LTD)InactiveTRANDOLAPRIL EP

DMF 206812007

BACHEM SAInactiveTRANDOLAPRIL

DMF 248552011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 12, 2007

No patent or exclusivity listings for this strength.

#002 — 2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 12, 2007

#003 — 4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 12, 2007